Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives

被引:14
|
作者
Diogo, Vania [1 ,2 ]
Teixeira, Joana [1 ,2 ]
Silva, Patricia M. A. [1 ,2 ,3 ]
Bousbaa, Hassan [1 ,4 ]
机构
[1] CESPU, Inst Invest & Formacao Avancada Ciencias & Tecnol, Inst Univ Ciencias Saude, Gandra, Paredes, Portugal
[2] Univ Algarve, Dept Ciencias Biomed & Med, Faro, Portugal
[3] Univ Algarve, Ctr Biomed Res CBMR, Faro, Portugal
[4] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental C, Oporto, Portugal
关键词
Aneuploidy; Cancer; Gene expression; Spindle checkpoint genes; Targeted therapy; AURORA KINASE INHIBITOR; SMALL-MOLECULE INHIBITOR; POLO-LIKE KINASES; MITOTIC CHECKPOINT; CHROMOSOMAL INSTABILITY; ANTITUMOR-ACTIVITY; COLON-CANCER; PHASE-I; SELECTIVE INHIBITOR; EXPRESSION PROFILES;
D O I
10.1016/j.clcc.2016.06.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer (CRC), one of the most common malignancies worldwide, is often diagnosed at an advanced stage, and resistance to chemotherapeutic and existing targeted therapy is a major obstacle to its successful treatment. New targets that offer alternative clinical options are therefore urgently needed. Recently, perturbation of the spindle assembly checkpoint (SAC), the surveillance mechanism that maintains anaphase inhibition until all chromosomes reach the metaphase plate, has been regarded as a promising target to fight cancer cells, either alone or in combination regimens. Consistent with this strategy, many cancers, including CRC, exhibit altered expression of SAC genes. In this article, we review our current knowledge on SAC activity status in CRC, and on current anti-CRC strategies and future therapeutic perspectives on the basis of SAC targeting experiments in vitro and in animal models. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] Current status and perspectives of immune checkpoint inhibitors for colorectal cancer
    Hirano, Hidekazu
    Takashima, Atsuo
    Hamaguchi, Tetsuya
    Shida, Dai
    Kanemitsu, Yukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (01) : 10 - 19
  • [2] An Overview of the Spindle Assembly Checkpoint Status in Oral Cancer
    Teixeira, Jose Henrique
    Silva, Patricia Manuela
    Reis, Rita Margarida
    Moura, Ines Moranguinho
    Marques, Sandra
    Fonseca, Joana
    Monteiro, Luis Silva
    Bousbaa, Hassan
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Current status and future perspective of immune checkpoint inhibitors in colorectal cancer
    Zhou, Cong
    Cheng, Xiaojiao
    Tu, Shuiping
    CANCER LETTERS, 2021, 521 : 119 - 129
  • [4] C-Met as a potential target for the treatment of gastrointestinal cancer: Current status and future perspectives
    Bahrami, Afsane
    Shahidsales, Soodabeh
    Khazaei, Majid
    Ghayour-Mobarhan, Majid
    Maftouh, Mina
    Hassanian, Seyed Mahdi
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2017, 232 (10) : 2657 - 2673
  • [5] Precision medicine for metastatic colorectal cancer; current status and future perspectives
    Taniguchi, Hiroya
    ANNALS OF ONCOLOGY, 2015, 26 : 42 - 42
  • [6] Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
    Kim, Tae Jin
    Koo, Kyo Chul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 16
  • [7] Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review)
    Al Bandar, Mahdi Hussain
    Nam Kyu Kim
    ONCOLOGY REPORTS, 2017, 37 (05) : 2553 - 2564
  • [8] Target-based therapies in breast cancer: current status and future perspectives
    Normanno, Nicola
    Morabito, Alessandro
    De Luca, Antonella
    Piccirillo, Maria Carmela
    Gallo, Marianna
    Maiello, Monica R.
    Perrone, Francesco
    ENDOCRINE-RELATED CANCER, 2009, 16 (03) : 675 - 702
  • [9] The current view for the silencing of the spindle assembly checkpoint
    Wang, Yanchang
    Jin, Fengzhi
    Higgins, Ryan
    McKnight, Kelly
    CELL CYCLE, 2014, 13 (11) : 1694 - 1701
  • [10] Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives
    Al-Attraqchi, Omar H. A.
    Attimarad, Mahesh
    Venugopala, Katharigatta N.
    Nair, Anroop
    Al-Attraqchi, Noor H. A.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (25) : 2716 - 2740